Connection

RONALD A DEPINHO to Cell Differentiation

This is a "connection" page, showing publications RONALD A DEPINHO has written about Cell Differentiation.
Connection Strength

2.073
  1. Telomere dysfunction drives aberrant hematopoietic differentiation and myelodysplastic syndrome. Cancer Cell. 2015 May 11; 27(5):644-57.
    View in: PubMed
    Score: 0.230
  2. From the Cover: Neutralization of terminal differentiation in gliomagenesis. Proc Natl Acad Sci U S A. 2013 Sep 03; 110(36):14520-7.
    View in: PubMed
    Score: 0.204
  3. PLAGL2 regulates Wnt signaling to impede differentiation in neural stem cells and gliomas. Cancer Cell. 2010 May 18; 17(5):497-509.
    View in: PubMed
    Score: 0.163
  4. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation. Nature. 2008 Oct 23; 455(7216):1129-33.
    View in: PubMed
    Score: 0.146
  5. Specific requirement of the chromatin modifier mSin3B in cell cycle exit and cellular differentiation. Proc Natl Acad Sci U S A. 2008 Mar 18; 105(11):4168-72.
    View in: PubMed
    Score: 0.140
  6. The differentiation and stress response factor XBP-1 drives multiple myeloma pathogenesis. Cancer Cell. 2007 Apr; 11(4):349-60.
    View in: PubMed
    Score: 0.131
  7. Telomere dysfunction alters intestinal stem cell dynamics to promote cancer. Dev Cell. 2024 Jun 03; 59(11):1475-1486.e5.
    View in: PubMed
    Score: 0.107
  8. Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell. 2002 Apr; 1(3):269-77.
    View in: PubMed
    Score: 0.093
  9. Contrasting roles for Myc and Mad proteins in cellular growth and differentiation. Proc Natl Acad Sci U S A. 1995 Aug 29; 92(18):8488-92.
    View in: PubMed
    Score: 0.059
  10. Contrasting roles for c-Myc and L-Myc in the regulation of cellular growth and differentiation in vivo. EMBO J. 1995 Feb 15; 14(4):743-56.
    View in: PubMed
    Score: 0.057
  11. Distinct requirements for Sin3a in perinatal male gonocytes and differentiating spermatogonia. Dev Biol. 2013 Jan 01; 373(1):83-94.
    View in: PubMed
    Score: 0.048
  12. Foxk1 promotes cell proliferation and represses myogenic differentiation by regulating Foxo4 and Mef2. J Cell Sci. 2012 Nov 15; 125(Pt 22):5329-37.
    View in: PubMed
    Score: 0.048
  13. Crosstalk between NOTCH and AKT signaling during murine megakaryocyte lineage specification. Blood. 2011 Aug 04; 118(5):1264-73.
    View in: PubMed
    Score: 0.044
  14. Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells. Nat Immunol. 2010 Jul; 11(7):618-27.
    View in: PubMed
    Score: 0.041
  15. FoxOs cooperatively regulate diverse pathways governing neural stem cell homeostasis. Cell Stem Cell. 2009 Nov 06; 5(5):540-53.
    View in: PubMed
    Score: 0.039
  16. Regulation of pancreatic juxtaductal endocrine cell formation by FoxO1. Mol Cell Biol. 2009 Aug; 29(16):4417-30.
    View in: PubMed
    Score: 0.038
  17. Pten and p53 converge on c-Myc to control differentiation, self-renewal, and transformation of normal and neoplastic stem cells in glioblastoma. Cold Spring Harb Symp Quant Biol. 2008; 73:427-37.
    View in: PubMed
    Score: 0.037
  18. Distinct functions for the transcription factor Foxo1 at various stages of B cell differentiation. Nat Immunol. 2008 Dec; 9(12):1388-98.
    View in: PubMed
    Score: 0.037
  19. A Foxo/Notch pathway controls myogenic differentiation and fiber type specification. J Clin Invest. 2007 Sep; 117(9):2477-85.
    View in: PubMed
    Score: 0.034
  20. FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell. 2007 Jan 26; 128(2):309-23.
    View in: PubMed
    Score: 0.032
  21. FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell. 2007 Jan 26; 128(2):325-39.
    View in: PubMed
    Score: 0.032
  22. Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Genes Dev. 2006 Nov 15; 20(22):3130-46.
    View in: PubMed
    Score: 0.032
  23. Pancreatic cancer biology and genetics. Nat Rev Cancer. 2002 Dec; 2(12):897-909.
    View in: PubMed
    Score: 0.024
  24. Malignant glioma: genetics and biology of a grave matter. Genes Dev. 2001 Jun 01; 15(11):1311-33.
    View in: PubMed
    Score: 0.022
  25. Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation. Oncogene. 1998 Apr 02; 16(13):1723-30.
    View in: PubMed
    Score: 0.018
  26. Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature. 1997 May 08; 387(6629):151-8.
    View in: PubMed
    Score: 0.017
  27. Drosophila Myc is oncogenic in mammalian cells and plays a role in the diminutive phenotype. Proc Natl Acad Sci U S A. 1997 Feb 18; 94(4):1235-40.
    View in: PubMed
    Score: 0.016
  28. Mouse Sin3A interacts with and can functionally substitute for the amino-terminal repression of the Myc antagonist Mxi1. Oncogene. 1996 Mar 07; 12(5):1165-72.
    View in: PubMed
    Score: 0.015
  29. Forkhead box O transcription factors in chondrocytes regulate endochondral bone formation. J Steroid Biochem Mol Biol. 2016 11; 164:337-343.
    View in: PubMed
    Score: 0.015
  30. Generation of functional insulin-producing cells in the gut by Foxo1 ablation. Nat Genet. 2012 Mar 11; 44(4):406-12, S1.
    View in: PubMed
    Score: 0.012
  31. AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias. Cell. 2011 Sep 02; 146(5):697-708.
    View in: PubMed
    Score: 0.011
  32. Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice. Nature. 2011 Jan 06; 469(7328):102-6.
    View in: PubMed
    Score: 0.011
  33. The FoxO3/type 2 deiodinase pathway is required for normal mouse myogenesis and muscle regeneration. J Clin Invest. 2010 Nov; 120(11):4021-30.
    View in: PubMed
    Score: 0.010
  34. Sin3a is required by sertoli cells to establish a niche for undifferentiated spermatogonia, germ cell tumors, and spermatid elongation. Stem Cells. 2010 Aug; 28(8):1424-34.
    View in: PubMed
    Score: 0.010
  35. Transcription factors Foxo3a and Foxo1 couple the E3 ligase Cbl-b to the induction of Foxp3 expression in induced regulatory T cells. J Exp Med. 2010 Jul 05; 207(7):1381-91.
    View in: PubMed
    Score: 0.010
  36. Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor. Nat Immunol. 2009 Feb; 10(2):176-84.
    View in: PubMed
    Score: 0.009
  37. mTORC1-dependent and -independent regulation of stem cell renewal, differentiation, and mobilization. Proc Natl Acad Sci U S A. 2008 Dec 09; 105(49):19384-9.
    View in: PubMed
    Score: 0.009
  38. Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma. Neuron. 2007 Feb 15; 53(4):503-17.
    View in: PubMed
    Score: 0.008
  39. Pten constrains centroacinar cell expansion and malignant transformation in the pancreas. Cancer Cell. 2005 Sep; 8(3):185-95.
    View in: PubMed
    Score: 0.007
  40. Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function. Genes Dev. 2004 Nov 01; 18(21):2614-26.
    View in: PubMed
    Score: 0.007
  41. STAT3 is a negative regulator of granulopoiesis but is not required for G-CSF-dependent differentiation. Immunity. 2002 Jul; 17(1):63-72.
    View in: PubMed
    Score: 0.006
  42. p16(Ink4a) in melanocyte senescence and differentiation. J Natl Cancer Inst. 2002 Mar 20; 94(6):446-54.
    View in: PubMed
    Score: 0.006
  43. N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation. Genes Dev. 2000 Jun 01; 14(11):1390-9.
    View in: PubMed
    Score: 0.005
  44. Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development. Nature. 2000 Apr 20; 404(6780):897-900.
    View in: PubMed
    Score: 0.005
  45. Neurotransmitter receptor activation triggers p27(Kip1 )and p21(CIP1) accumulation and G1 cell cycle arrest in oligodendrocyte progenitors. Development. 1999 Feb; 126(5):1077-90.
    View in: PubMed
    Score: 0.005
  46. Cooperation between the Cdk inhibitors p27(KIP1) and p57(KIP2) in the control of tissue growth and development. Genes Dev. 1998 Oct 15; 12(20):3162-7.
    View in: PubMed
    Score: 0.005
  47. Human CPR (cell cycle progression restoration) genes impart a Far- phenotype on yeast cells. Genetics. 1997 Nov; 147(3):1063-76.
    View in: PubMed
    Score: 0.004
  48. Functional interactions among members of the Myc superfamily and potential relevance to cutaneous growth and development. J Investig Dermatol Symp Proc. 1996 Apr; 1(2):128-35.
    View in: PubMed
    Score: 0.004
  49. Lens complementation system for the genetic analysis of growth, differentiation, and apoptosis in vivo. Proc Natl Acad Sci U S A. 1996 Feb 06; 93(3):1303-7.
    View in: PubMed
    Score: 0.004
  50. IgH enhancer deregulated expression of L-myc: abnormal T lymphocyte development and T cell lymphomagenesis. EMBO J. 1990 Nov; 9(11):3659-66.
    View in: PubMed
    Score: 0.003
  51. IgH enhancer-mediated deregulation of N-myc gene expression in transgenic mice: generation of lymphoid neoplasias that lack c-myc expression. EMBO J. 1989 Apr; 8(4):1121-8.
    View in: PubMed
    Score: 0.002
  52. Differential expression of myc-family genes during development: normal and deregulated N-myc expression in transgenic mice. Curr Top Microbiol Immunol. 1988; 141:100-9.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.